Publication:
Transplantation opportunities of hepatitis C virus-seropositive patients on the kidney waiting list

dc.contributor.buuauthorOruç, Ayşegül
dc.contributor.buuauthorErsoy, Alparslan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.departmentNefroloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-0710-0923
dc.contributor.orcid0000-0002-0342-9692
dc.contributor.researcheridAAH-5054-2021
dc.contributor.researcheridAAH-4002-2021
dc.contributor.scopusid55133912100
dc.contributor.scopusid35612977100
dc.date.accessioned2023-11-20T13:32:54Z
dc.date.available2023-11-20T13:32:54Z
dc.date.issued2018-12
dc.description.abstractObjective. Besides severe organ shortage, hepatitis C virus (HCV) infection is an important obstacle for kidney transplantation because of long waiting times on deceased kidney donor waiting lists. We aimed to evaluate calling number of candidates according to HCV serology. Method. A total of 404 adults on the deceased donor waiting list invited for cadaveric transplantation was evaluated. Demographic data, waiting time, calling number for transplantation, and viral serology were obtained during the 6-year period. Results. Mean waiting duration and calling number of all patients were 42.7 +/- 34 months and 1.56 +/- 4.37 times, respectively. Twenty-six candidates had chronic HCV infection and 12 of 26 were HCV RNA-positive. Mean waiting duration and calling number in anti-HCV-positive candidates were significantly higher compared with anti-HCV-negative candidates (85.3 +/- 38.8 vs 39.8 +/- 31.6 months, and 10.8 +/- 10.3 vs 0.92 +/- 2.6 times, respectively; P < .001). Mean waiting duration and total calling number in HCV-RNA-positive candidates were significantly higher than in HCV-RNA-negative ones (107.5 +/- 7.5 vs 66.2 +/- 44.8 months; P = .018; 15 +/- 9.7 vs 7.3 +/- 9.8 times, respectively; P = .026). Conclusions. Chronic HCV infection is an important issue leading to longer waiting time on the list. Our observation showed that waiting durations of anti-HCV-positive candidates were longer than that of negative patients, although they had more frequent opportunity for transplantation.
dc.identifier.citationOruç, A. ve Ersoy, A. (2018). ''Transplantation opportunities of hepatitis C virus-seropositive patients on the kidney waiting list''. Transplantation Proceedings, 50(10), 3181-3184.
dc.identifier.endpage3184
dc.identifier.issn0041-1345
dc.identifier.issn1873-2623
dc.identifier.issue10
dc.identifier.pubmed29803528
dc.identifier.scopus2-s2.0-85047297587
dc.identifier.startpage3181
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2018.04.044
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0041134518306146
dc.identifier.urihttp://hdl.handle.net/11452/34953
dc.identifier.volume50
dc.identifier.wos000454972000043
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.journalTransplantation Proceedings
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectImmunology
dc.subjectSurgery
dc.subjectTransplantation
dc.subjectAntiviral therapy
dc.subjectDialysis patients
dc.subjectInfection
dc.subjectDisease
dc.subjectRecipients
dc.subjectSurvivals
dc.subjectSafety
dc.subjectDonors
dc.subjectGraft
dc.subjectRNA
dc.subject.emtreePeginterferon
dc.subject.emtreeRibavirin
dc.subject.emtreeVirus RNA
dc.subject.emtreeAdult
dc.subject.emtreeAge distribution
dc.subject.emtreeArticle
dc.subject.emtreeChronic hepatitis C
dc.subject.emtreeControlled study
dc.subject.emtreeDeceased donor
dc.subject.emtreeFemale
dc.subject.emtreeGenotype
dc.subject.emtreeHospital admission
dc.subject.emtreeHuman
dc.subject.emtreeKidney transplantation
dc.subject.emtreeLiving donor
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMiddle aged
dc.subject.emtreePriority journal
dc.subject.emtreeRetrospective study
dc.subject.emtreeSerology
dc.subject.emtreeSex ratio
dc.subject.emtreeSustained virologic response
dc.subject.emtreeChronic hepatitis C
dc.subject.emtreeComplication
dc.subject.emtreeDonor
dc.subject.emtreeHepacivirus
dc.subject.emtreeKidney transplantation
dc.subject.emtreeMortality
dc.subject.emtreeProcedures
dc.subject.emtreeStatistics and numerical data
dc.subject.emtreeTurkey (bird)
dc.subject.meshAdult
dc.subject.meshFemale
dc.subject.meshHepacivirus
dc.subject.meshHepatitis C.
dc.subject.meshChronic
dc.subject.meshHumans
dc.subject.meshKidney transplantation
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshTissue donors
dc.subject.meshTurkey
dc.subject.meshWaiting lists
dc.subject.scopusSustained Virologic Response; Hepatitis C Virus; Antivirus Agent
dc.subject.wosImmunology
dc.subject.wosSurgery
dc.subject.wosTransplantation
dc.titleTransplantation opportunities of hepatitis C virus-seropositive patients on the kidney waiting list
dc.typeArticle
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı/Nefroloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: